Welltower (NYSE:WELL) Given New $166.00 Price Target at Scotiabank

Welltower (NYSE:WELL) had its target price lifted by Scotiabank from $165.00 to $166.00 in a report released on Thursday,Benzinga reports. They currently have a sector outperform rating on the real estate investment trust’s stock.

Several other analysts also recently commented on WELL. Raymond James boosted their target price on shares of Welltower from $145.00 to $155.00 and gave the stock a “strong-buy” rating in a research report on Monday, December 16th. Evercore ISI boosted their price objective on shares of Welltower from $144.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday. Royal Bank of Canada upgraded shares of Welltower from a “sector perform” rating to an “outperform” rating and boosted their price objective for the stock from $146.00 to $168.00 in a research note on Friday, February 28th. Jefferies Financial Group upgraded shares of Welltower from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $132.00 to $147.00 in a research note on Thursday, January 2nd. Finally, Mizuho boosted their price objective on shares of Welltower from $136.00 to $141.00 and gave the stock an “outperform” rating in a research note on Thursday, December 5th. One research analyst has rated the stock with a sell rating, two have given a hold rating, ten have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Welltower currently has a consensus rating of “Moderate Buy” and a consensus price target of $148.42.

Welltower Stock Performance

WELL stock opened at $148.93 on Thursday. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $95.51 billion, a price-to-earnings ratio of 95.46, a P/E/G ratio of 2.87 and a beta of 1.20. Welltower has a 12 month low of $87.87 and a 12 month high of $158.55. The firm has a 50 day moving average of $138.55 and a two-hundred day moving average of $132.41.

Welltower (NYSE:WELL) last posted its earnings results on Tuesday, February 11th. The real estate investment trust reported $1.13 EPS for the quarter, topping the consensus estimate of $0.40 by $0.73. Welltower had a net margin of 11.91% and a return on equity of 3.15%. As a group, equities analysts anticipate that Welltower will post 4.88 EPS for the current fiscal year.

Welltower Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 6th. Stockholders of record on Tuesday, February 25th were paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date was Tuesday, February 25th. Welltower’s dividend payout ratio is 171.79%.

Hedge Funds Weigh In On Welltower

Hedge funds have recently made changes to their positions in the business. Roxbury Financial LLC acquired a new position in shares of Welltower in the 4th quarter valued at $26,000. Laurel Wealth Advisors LLC acquired a new position in shares of Welltower in the 4th quarter valued at $25,000. Sierra Ocean LLC acquired a new position in shares of Welltower in the 4th quarter valued at $28,000. Versant Capital Management Inc raised its stake in shares of Welltower by 165.5% in the 4th quarter. Versant Capital Management Inc now owns 300 shares of the real estate investment trust’s stock valued at $38,000 after buying an additional 187 shares in the last quarter. Finally, Ashton Thomas Securities LLC acquired a new position in shares of Welltower in the 3rd quarter valued at $50,000. Institutional investors and hedge funds own 94.80% of the company’s stock.

About Welltower

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.